Feng Chi Biotech (ROCO:6744) EV-to-EBIT : 5.38 (As of May. 16, 2024)

View and export this data going back to 2019. Start your Free Trial

What is Feng Chi Biotech EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Feng Chi Biotech's Enterprise Value is NT$148.6 Mil. Feng Chi Biotech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was NT$27.6 Mil. Therefore, Feng Chi Biotech's EV-to-EBIT for today is 5.38.

The historical rank and industry rank for Feng Chi Biotech's EV-to-EBIT or its related term are showing as below:

ROCO:6744' s EV-to-EBIT Range Over the Past 10 Years
Min: 1.83 Med: 5.99 Max: 20.88
Current: 5.37

During the past 8 years, the highest EV-to-EBIT of Feng Chi Biotech was 20.88. The lowest was 1.83. And the median was 5.99.

ROCO:6744's EV-to-EBIT is ranked better than
57.58% of 429 companies
in the Biotechnology industry
Industry Median: 9.84 vs ROCO:6744: 5.37

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Feng Chi Biotech's Enterprise Value for the quarter that ended in Dec. 2023 was NT$147.8 Mil. Feng Chi Biotech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was NT$27.6 Mil. Feng Chi Biotech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 18.69%.

Feng Chi Biotech EV-to-EBIT Historical Data

The historical data trend for Feng Chi Biotech's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Feng Chi Biotech EV-to-EBIT Chart

Feng Chi Biotech Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

Get a 7-Day Free Trial

14.55

8.00

5.43

2.82

5.35

Feng Chi Biotech Semi-Annual Data
	Dec16	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial									5.43	-	2.82	-	5.35

Competitive Comparison of Feng Chi Biotech's EV-to-EBIT

For the Biotechnology subindustry, Feng Chi Biotech's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Feng Chi Biotech's EV-to-EBIT Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Feng Chi Biotech's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Feng Chi Biotech's EV-to-EBIT falls into.

Feng Chi Biotech EV-to-EBIT Calculation

Feng Chi Biotech's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	148.559	/	27.624
	=	5.38

Feng Chi Biotech's current Enterprise Value is NT$148.6 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Feng Chi Biotech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was NT$27.6 Mil.

Feng Chi Biotech (ROCO:6744) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Feng Chi Biotech's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 )	=	EBIT	/	Enterprise Value (Q: Dec. 2023 )
	=	27.624	/	147.789
	=	18.69 %

Feng Chi Biotech's Enterprise Value for the quarter that ended in Dec. 2023 was NT$147.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Feng Chi Biotech's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was NT$27.6 Mil.

Feng Chi Biotech EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Feng Chi Biotech's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Feng Chi Biotech (ROCO:6744) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Feng Chi Biotech Corp (ROCO:6744) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 5, Shaoxing North Street, 5th Floor-1, Zhongzheng District, Taipei City, TWN, 100

Website

http://www.fcbiotech.com.tw

Feng Chi Biotech Corp provide promotion and support for clinical testing and molecular genetic medicine research related technologies. The company's products and services include clinical testing, food testing, newborn screening, prenatal screening, iron stomach, interscience, and colony counting.

Feng Chi Biotech (ROCO:6744) Headlines

No Headlines